Universal Health Realty Income Trust (UHT) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
17 Jun, 2026Executive summary
Net income for Q1 2026 was $5.0 million ($0.36 per diluted share), up from $4.8 million ($0.34 per diluted share) in Q1 2025, driven by lower interest expense and increased property income.
Funds from operations (FFO) increased to $12.3 million ($0.88 per diluted share) from $11.9 million ($0.86 per diluted share) year-over-year.
Revenues were stable at $24.5 million for both Q1 2026 and Q1 2025, with UHS-related tenants accounting for 41% of consolidated revenues.
A quarterly dividend of $0.745 per share ($10.3 million total) was declared and paid.
Financial highlights
Lease revenue from UHS facilities was $8.4 million, and from non-related parties $14.2 million in Q1 2026.
Interest income on financing leases was $1.3 million.
Depreciation and amortization expense was $7.0 million; interest expense decreased to $4.45 million.
Basic and diluted EPS were $0.36 for Q1 2026, compared to $0.35 and $0.34, respectively, in Q1 2025.
Total assets at March 31, 2026 were $563.8 million; total equity was $147.8 million.
Outlook and guidance
Management expects sufficient capital resources for the next twelve months, including distributions to maintain REIT status.
No guidance changes or material updates to critical accounting policies were reported.
Construction of Miller Medical Plaza began in February 2026, with completion expected in Q4 2026 and a 10-year master lease for 75% of rentable space already secured.
Management highlighted ongoing risks from interest rate increases, healthcare industry regulation, and macroeconomic factors affecting tenants.
Latest events from Universal Health Realty Income Trust
- Trustee elections, executive pay, and auditor ratification all passed with no shareholder questions.UHT
AGM 202622 Jun 2026 - Trustees, executive pay, and auditor were approved by shareholders in a virtual meeting.UHT
AGM 202522 Jun 2026 - All proposals, including trustee elections and auditor ratification, were approved by shareholders.UHT
AGM 202421 Jun 2026 - Q2 and H1 2024 net income and FFO rose, with higher dividends and ongoing industry risks.UHT
Q2 202417 Jun 2026 - Net income, revenues, and FFO rose, with higher interest costs and expanded credit capacity.UHT
Q3 202417 Jun 2026 - Net income and FFO rose year-over-year, supported by property income and prudent capital actions.UHT
Q4 202417 Jun 2026 - Raised 2025 guidance after strong Q2 results and incremental Medicaid reimbursements.UHT
Q2 202517 Jun 2026 - Net income and FFO dipped, with new development underway and higher borrowing costs noted.UHT
Q4 202517 Jun 2026 - Mixed earnings and revenue trends, with stable liquidity but ongoing regulatory and litigation risks.UHT
Q1 202517 Jun 2026